Compare BIRK & ICLR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | BIRK | ICLR |
|---|---|---|
| Founded | 1774 | 1990 |
| Country | United Kingdom | Ireland |
| Employees | N/A | N/A |
| Industry | | Biotechnology: Commercial Physical & Biological Resarch |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 7.0B | 8.2B |
| IPO Year | 2023 | 2001 |
| Metric | BIRK | ICLR |
|---|---|---|
| Price | $41.74 | $117.25 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 13 | 13 |
| Target Price | $62.08 | ★ $178.62 |
| AVG Volume (30 Days) | ★ 1.9M | 820.2K |
| Earning Date | 05-13-2026 | 04-30-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $13.71 | N/A |
| Revenue Next Year | $14.30 | N/A |
| P/E Ratio | $17.48 | ★ $12.91 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $33.06 | $66.57 |
| 52 Week High | $57.39 | $211.00 |
| Indicator | BIRK | ICLR |
|---|---|---|
| Relative Strength Index (RSI) | 64.57 | 59.77 |
| Support Level | $40.55 | $102.53 |
| Resistance Level | $42.19 | $182.55 |
| Average True Range (ATR) | 1.67 | 5.03 |
| MACD | 0.63 | 1.98 |
| Stochastic Oscillator | 99.14 | 82.92 |
Birkenstock is a German footwear brand known for comfort-focused, timeless designs, with 76% of 2022 sales coming from its top five iconic models. Products are made in Europe using sustainable, mostly locally sourced materials. The brand combines orthopedic function with everyday style, appealing to a broad audience. The Americas account for 52% of sales, EMEA 37%, with the remainder coming from Asia-Pacific, which has also the higher future growth expectations.
Icon is a global contract research organization that provides outsourced clinical development services to pharmaceutical and biotechnology firms. Icon supports clients across late-stage clinical trials through the regulatory approval process and postmarket studies. Icon's services include clinical trial management, patient recruitment, data analytics, laboratory services, and regulatory consulting. With more than 40,000 employees operating in over 50 countries, the company partners with life sciences firms to run clinical trials and bring new drugs to market.